Literature DB >> 9765345

Characterization of cembranoid interaction with the nicotinic acetylcholine receptor.

R M Hann1, O R Pagán, L Gregory, T Jácome, A D Rodríguez, P A Ferchmin, R Lu, V A Eterović.   

Abstract

The class of diterpenoids with a 14-carbon cembrane ring, the cembranoids, includes both competitive and noncompetitive inhibitors of the nicotinic acetylcholine receptor (AChR). All 20 coelenterate-derived cembranoids studied in this report inhibited [piperidyl-3,4-3H]-phencyclidine ([3H]-PCP) binding to its high-affinity site on the electric organ AChR, with IC50s ranging from 0.9 microM for methylpseudoplexaurate to 372 microM for lophotoxin. Inhibition was complete with all cembranoids but lophotoxin and most Hill coefficients were close to 1. Methylpseudoplexaurate and [3H]-PCP binding was competitive. Methylpseudoplexaurate and the fourth most potent cembranoid, eunicin, competed with each other for [3H]-PCP displacement, indicating that there exist one or more cembranoid sites on the AChR. Cembranoid affinity for the AChR correlated with hydrophobicity, but was also dependent on other features. Methylpseudoplexaurate and n-octanol also competed with each other for [3H]-PCP displacement, indicating that the cembranoid site is linked to the n-octanol site on the AChR. Unlike lophotoxin, the five cembranoids tested did not inhibit [125I]Tyr54-alpha-bungarotoxin binding to the AChR agonist sites. All seven cembranoids tested on oocyte-expressed electric organ AChR reversibly blocked acetylcholine-induced currents, although the inhibitor concentration curves were shallow and the inhibition was incomplete.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765345

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Determinants of phencyclidine potency on the nicotinic acetylcholine receptors from muscle and electric organ.

Authors:  V A Eterović; R Lu; A E Eakin; A D Rodríguez; P A Ferchmin
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

2.  In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor.

Authors:  H Ulrich; J E Ippolito; O R Pagán; V A Eterović; R M Hann; H Shi; J T Lis; M E Eldefrawi; G P Hess
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

3.  Structural determinants in phycotoxins and AChBP conferring high affinity binding and nicotinic AChR antagonism.

Authors:  Yves Bourne; Zoran Radic; Rómulo Aráoz; Todd T Talley; Evelyne Benoit; Denis Servent; Palmer Taylor; Jordi Molgó; Pascale Marchot
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-11       Impact factor: 11.205

4.  Neuroprotective activity of (1S,2E,4R,6R,-7E,11E)-2,7,11-cembratriene-4,6-diol (4R) in vitro and in vivo in rodent models of brain ischemia.

Authors:  Antonio H Martins; Jing Hu; Zhenfeng Xu; Chaofeng Mu; Paloma Alvarez; Byron D Ford; Khalid El Sayed; Vesna A Eterovic; Pedro A Ferchmin; Jiukuan Hao
Journal:  Neuroscience       Date:  2015-02-10       Impact factor: 3.590

Review 5.  Actions of octocoral and tobacco cembranoids on nicotinic receptors.

Authors:  P A Ferchmin; Oné R Pagán; Henning Ulrich; Ada C Szeto; Richard M Hann; Vesna A Eterović
Journal:  Toxicon       Date:  2009-03-10       Impact factor: 3.033

6.  A cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms.

Authors:  Oné R Pagán; Amanda L Rowlands; Angela L Fattore; Tamara Coudron; Kimberly R Urban; Apurva H Bidja; Vesna A Eterović
Journal:  Eur J Pharmacol       Date:  2009-05-30       Impact factor: 4.432

7.  Identification of crassin acetate as a new immunosuppressant triggering heme oxygenase-1 expression in dendritic cells.

Authors:  Hironori Matsushima; Hiroaki Tanaka; Norikatsu Mizumoto; Akira Takashima
Journal:  Blood       Date:  2009-04-28       Impact factor: 22.113

8.  Mechanisms of potentiation of the mammalian GABAA receptor by the marine cembranoid eupalmerin acetate.

Authors:  P Li; D E Reichert; A D Rodríguez; B D Manion; A S Evers; V A Eterović; J H Steinbach; G Akk
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

9.  4R-cembranoid protects neuronal cells from oxygen-glucose deprivation by modulating microglial cell activation.

Authors:  Hefei Fu; Jiapeng Wang; Jie Wang; Langni Liu; Jianxiong Jiang; Jiukuan Hao
Journal:  Brain Res Bull       Date:  2021-12-20       Impact factor: 4.077

10.  4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's Disease.

Authors:  Jing Hu; P A Ferchmin; Ann M Hemmerle; Kim B Seroogy; Vesna A Eterovic; Jiukuan Hao
Journal:  Front Neurosci       Date:  2017-05-29       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.